Search

Your search keyword '"Antiviral agents -- Product introduction"' showing total 10 results
Start Over Descriptor "Antiviral agents -- Product introduction" Publisher newsrx llc
10 results on '"Antiviral agents -- Product introduction"'

1. Current Trends and Growth Indications in the Global Anti-Infectives Market to 2011

Subjects
Marketing research, Company growth, Pharmaceutical industry -- Market research, Pharmaceutical industry -- Industry forecasts, Pharmaceutical industry -- Product introduction, Pharmaceutical industry -- Reports, Pharmaceutical industry -- Growth, Antiviral agents -- Market research, Antiviral agents -- Product introduction, Antiviral agents -- Reports, Antiviral agents -- Growth
Abstract

Reportlinker.com announces that a new market research report related to the worldwide pharmaceutical industry is now available to its catalogue. The Global Anti-Infectives Market Outlook to 2011 http://www.reportlinker.com/p051035/anti-infectives .html The [...]

Published
2007

2. New AIDS drug arrives at pharmacies

Subjects
Pharmacia & Upjohn Inc. -- Product introduction -- 00360112, Rescriptor (Medication) -- Product introduction, Antiviral agents -- Product introduction, HIV infection -- Drug therapy
Abstract

Pharmacia & Upjohn (P&U), Kalamazoo, Michigan, announced that shipments of Rescriptor tablets (delavirdine mesylate) have been made available at pharmacies throughout the United States. With combination therapy believed to be [...]

Published
1997

3. Lamivudine released by FDA under traditional regulations

Subjects
Epivir (Medication) -- Product introduction, Antiviral agents -- Product introduction, HIV infection -- Drug therapy
Abstract

On the strength of an international study which recently showed Epivir (lamivudine; 3TC) to be effective in reducing the risk of death and disease progression in persons with AIDS, the [...]

Published
1997

4. Drug announced to receive FDA marketing clearance

Subjects
Pharmacia & Upjohn Inc. -- Product introduction -- 00360112, Rescriptor (Medication) -- Product introduction, Antiviral agents -- Product introduction
Abstract

Pharmacia & Upjohn (P&U), London, United Kingdom, announced that the U.S. Food and Drug Administration (FDA) has granted the company marketing clearance for Rescriptor Tablets (delavirdine mesylate tablets), a new [...]

Published
1997

5. NDA planned for submission of Viracept anti-HIV drug

Subjects
Agouron Pharmaceuticals Inc. -- Product introduction, Viracept (Medication) -- Product introduction, Protease inhibitors -- Product introduction, Antiviral agents -- Product introduction
Abstract

Agouron Pharmaceuticals, Inc., La Jolla, California, has planned to proceed to assemble and file with the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) seeking approval to [...]

Published
1996

6. Drug available for treatment of recurrent genital herpes

Subjects
SmithKline Beecham Corp. -- Product introduction -- 00307917, Famvir (Medication) -- Product introduction, Antiviral agents -- Product introduction, Herpes genitalis -- Drug therapy, Pharmaceutical industry -- Product introduction
Abstract

SmithKline Beecham, Philadelphia, Pennsylvania, announced that Famvir (famciclovir) is available nationwide to Treat genital herpes. Famvir, an antiviral drug that requires less frequent dosing than the medication commonly used to [...]

Published
1996

7. Company announces FDA approval for HIV drug

Subjects
Bristol-Myers Squibb Co. -- Product introduction, Zerit (Medication) -- Product introduction, Antiviral agents -- Product introduction, HIV infection -- Drug therapy
Abstract

DATELINE: Drug Approval Bristol-Myers Squibb Company announced that it has received U.S. Food and Drug Administration (FDA) clearance to market Zerit (stavudine), a new anti -retroviral agent to treat persons [...]

Published
1994

8. Bristol-Myers Squibb files NDA for anti-AIDS drug Zerit (stavudine, d4T)

Subjects
Bristol-Myers Squibb Co. -- Product introduction, Zerit (Medication) -- Product introduction, Antiviral agents -- Product introduction, Nucleoside analogs -- Product introduction
Abstract

New York Bristol-Myers Squibb Company, New York, New York, announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval to [...]

Published
1994

9. Enzyme-based antiseptic reportedly kills HIV on contact

Subjects
ExOxEmis Inc. -- Product introduction, HIV infection -- Drug therapy, Antiviral agents -- Product introduction, Peroxidase -- Health aspects, Eosinophils -- Health aspects
Abstract

ExOxEmis Inc. ExOxEmis, Little Rock, Arkansas, reports to have developed two enzymes, Myeloperoxidase (MPO) and Eosinophil Peroxidase (EPO), trade named Exact, which kill HIV on contact. Jackson T. Stephens Jr., [...]

Published
1992

10. Conference Coverage (Retrovirus): New Glaxo RT Inhibitor: Potent But Toxic To Some

Author

DeNoon, Daniel J.

Subjects
Glaxo Inc. -- Product introduction -- 00043723, AIDS (Disease) -- Drug therapy, Antiviral agents -- Product introduction
Abstract

Despite severe toxicities in up to 5 percent of patients, Glaxo's potent new AIDS drug is poised to enter the market. The drug is abacavir, formerly known by the code [...]

Published
1998

Catalog

Books, media, physical & digital resources
See catalog results